Blind docking of drug-sized compounds to proteins with up to a thousand residues

scientific article published on 31 January 2006

Blind docking of drug-sized compounds to proteins with up to a thousand residues is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.FEBSLET.2006.01.074
P698PubMed publication ID16460734
P5875ResearchGate publication ID7313016

P50authorDavid van der SpoelQ47087753
P2093author name stringCsaba Hetényi
P2860cites workRefinement of docked protein-ligand and protein-DNA structures using low frequency normal mode amplitude optimizationQ24811274
Anesthetic interaction with ketosteroid isomerase: insights from molecular dynamics simulations.Q30995948
Molecular recognition and docking algorithmsQ31130825
Ligand binding: functional site location, similarity and dockingQ35165255
Ligand-dependent linkage of the ATP site to inhibition gate closure in the KATP channelQ36493543
Efficient docking of peptides to proteins without prior knowledge of the binding siteQ38270145
Computational comparison of microtubule-stabilising agents laulimalide and peloruside with taxol and colchicineQ40485772
Design, structure and biological activity of beta-turn peptides of CD2 protein for inhibition of T-cell adhesionQ40539360
A comprehensive docking study on the selectivity of binding of aromatic compounds to proteinsQ40560992
Exploring blocker binding to a homology model of the open hERG K+ channel using docking and molecular dynamics methodsQ42656435
Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDockQ43825573
Creating artificial binding pocket boundaries to improve the efficiency of flexible ligand dockingQ44992312
Computational prediction of structure, substrate binding mode, mechanism, and rate for a malaria protease with a novel type of active siteQ45150900
Multiple ligand-binding modes in bacterial R67 dihydrofolate reductaseQ46628596
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)1447-1450
P577publication date2006-01-31
P1433published inFEBS LettersQ1388051
P1476titleBlind docking of drug-sized compounds to proteins with up to a thousand residues
P478volume580

Reverse relations

cites work (P2860)
Q51596270A spectral deciphering of the binding interaction of an intramolecular charge transfer fluorescence probe with a cationic protein: thermodynamic analysis of the binding phenomenon combined with blind docking study.
Q42315007A structure- and chemical genomics-based approach for repositioning of drugs against VCP/p97 ATPase.
Q34731493A threading-based method (FINDSITE) for ligand-binding site prediction and functional annotation
Q36740574A unique mode of microtubule stabilization induced by peloruside A
Q37265658Affinity and specificity of levamlodipine-human serum albumin interactions: insights into its carrier function
Q58556643An integrated molecular modeling approach for the tryptase monomer-curcuminoid recognition analysis: conformational and bioenergetic features
Q41973458Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivatives
Q42362394Analysis of the interaction of calcitriol with the disulfide isomerase ERp57.
Q39079147Ansamitocin P3 depolymerizes microtubules and induces apoptosis by binding to tubulin at the vinblastine site
Q48260352Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors
Q28551247AutoDockFR: Advances in Protein-Ligand Docking with Explicitly Specified Binding Site Flexibility
Q34040043BSP-SLIM: a blind low-resolution ligand-protein docking approach using predicted protein structures
Q91530373CB-Dock: a web server for cavity detection-guided protein-ligand blind docking
Q35181207Can structural features of kinase receptors provide clues on selectivity and inhibition? A molecular modeling study
Q35206344Challenges, applications, and recent advances of protein-ligand docking in structure-based drug design.
Q26779035Charting a Path to Success in Virtual Screening
Q92249524Coagulation Factor XIIIa Inhibitor Tridegin: On the Role of Disulfide Bonds for Folding, Stability, and Function
Q42939604Comparison of structure-based and threading-based approaches to protein functional annotation
Q38886443Competitive binding at a nicotinic receptor transmembrane site of two α7-selective positive allosteric modulators with differing effects on agonist-evoked desensitization
Q39743323Computational analysis of EBNA1 "druggability" suggests novel insights for Epstein-Barr virus inhibitor design
Q34325628Computational predictions of volatile anesthetic interactions with the microtubule cytoskeleton: implications for side effects of general anesthesia
Q47380401Dataset generated for Dissection of mechanisms of Trypanothione Reductase and Tryparedoxin Peroxidase through dynamic network analysis and simulations in leishmaniasis
Q47305260Deciphering how Cpl-7 cell wall-binding repeats recognize the bacterial peptidoglycan
Q39667620Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives
Q51440878Differential interactions of a biological photosensitizer with liposome membranes having varying surface charges.
Q47146818Dynamic changes in binding interaction networks of sex steroids establish their non-classical effects
Q50505675Effect of biological confinement on the photophysics and dynamics of a proton-transfer phototautomer: an exploration of excitation and emission wavelength-dependent photophysics of the protein-bound drug.
Q56969963Epistructural Dynamics of Biological Water
Q28478619Exploring the landscape of protein-ligand interaction energy using probabilistic approach
Q37215648FINDSITE: a combined evolution/structure-based approach to protein function prediction
Q46581744Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation
Q36426352Flavin Binding to the Deca-heme Cytochrome MtrC: Insights from Computational Molecular Simulation
Q35661996Force Field Benchmark of Organic Liquids: Density, Enthalpy of Vaporization, Heat Capacities, Surface Tension, Isothermal Compressibility, Volumetric Expansion Coefficient, and Dielectric Constant
Q38571414Functioning of drug-metabolizing microsomal cytochrome P450s: In silico probing of proteins suggests that the distal heme 'active site' pocket plays a relatively 'passive role' in some enzyme-substrate interactions
Q84417497Homology modeling of the structure of acyl coA:isopenicillin N-acyltransferase (IAT) from Penicillium chrysogenum. IAT interaction studies with isopenicillin-N, combining molecular dynamics simulations and docking
Q39280041How does a drug molecule find its target binding site?
Q39002382Identification of Key Residues for Urate Specific Transport in Human Glucose Transporter 9 (hSLC2A9).
Q34219538Identification of selective inhibitors of the potassium channel Kv1.1-1.2((3)) by high-throughput virtual screening and automated patch clamp
Q30370764Improving accuracy and efficiency of blind protein-ligand docking by focusing on predicted binding sites.
Q89597711In Silico Strategies in Tuberculosis Drug Discovery
Q92729474In silico and in vitro evaluation of tetrahydropyridine compounds as efflux inhibitors in Mycobacterium abscessus
Q53362559Insights into the Interaction Mechanism of Ligands with Aβ42 Based on Molecular Dynamics Simulations and Mechanics: Implications of Role of Common Binding Site in Drug Design for Alzheimer's Disease.
Q87345890Insights into the influence of 5-HT2c aminoacidic variants with the inhibitory action of serotonin inverse agonists and antagonists
Q89510669Integrated Computational Approaches and Tools forAllosteric Drug Discovery
Q35649957Interaction between the Natural Components in Danhong Injection (DHI) with Serum Albumin (SA) and the Influence of the Coexisting Multi-Components on the SaB-BSA Binding System: Fluorescence and Molecular Docking Studies
Q58773595Interaction of 2'R-ochratoxin A with Serum Albumins: Binding Site, Effects of Site Markers, Thermodynamics, Species Differences of Albumin-binding, and Influence of Albumin on Its Toxicity in MDCK Cells
Q36401456Interaction of Citrinin with Human Serum Albumin
Q90264468Interactions of zearalenone and its reduced metabolites α-zearalenol and β-zearalenol with serum albumins: species differences, binding sites, and thermodynamics
Q46275221Investigation of Non-Covalent Interactions of Aflatoxins (B1, B2, G1, G2, and M1) with Serum Albumin.
Q31151838Investigation of the interaction between the atypical agonist c[YpwFG] and MOR.
Q90193662Key Topics in Molecular Docking for Drug Design
Q37701430LIBSA--a method for the determination of ligand-binding preference to allosteric sites on receptor ensembles
Q42657141Molecular dynamics simulation analysis of Focal Adhesive Kinase (FAK) docked with solanesol as an anti-cancer agent
Q36526260Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists
Q33590792Molecular modeling of lanthionine synthetase component C-like protein 2: a potential target for the discovery of novel type 2 diabetes prophylactics and therapeutics
Q34775341Multi-haem cytochromes in Shewanella oneidensis MR-1: structures, functions and opportunities
Q92987428Multifunctional Peptides from Spanish Dry-Cured Pork Ham: Endothelial Responses and Molecular Modeling Studies
Q36337739Novel ligands that target the mitochondrial membrane protein mitoNEET
Q58846278POSE SCALING: GEOMETRICAL ASSESSMENT OF LIGAND BINDING POSES
Q56970096Packing Defects and Protein Hydration: Dynamics of the Aqueous Interface
Q28475112Palmitic acid analogs exhibit nanomolar binding affinity for the HIV-1 CD4 receptor and nanomolar inhibition of gp120-to-CD4 fusion
Q34262313Pharmacophore-based virtual screening to aid in the identification of unknown protein function
Q49957326Potential Breast Anticancer Drug Targets Revealed by Differential Gene Regulatory Network Analysis and Molecular Docking: Neoadjuvant Docetaxel Drug as a Case Study.
Q38302492Potential mechanism of action of meso-dihydroguaiaretic acid on Mycobacterium tuberculosis H37Rv.
Q34827173Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site
Q51911024Solvent-exposed backbone loosens the hydration shell of soluble folded proteins.
Q57781260Structural investigations into the binding mode of novel neolignans Cmp10 and Cmp19 microtubule stabilizers byin silicomolecular docking, molecular dynamics, and binding free energy calculations
Q80162928Structure-based calculation of binding affinities of alpha 2A-adrenoceptor agonists
Q54433838Structure-function relationships of the human bitter taste receptor hTAS2R1: insights from molecular modeling studies.
Q47667688Synthesis and spectroscopic characterization study of new palladium complexes containing bioactive O,O-chelated ligands: evaluation of the DNA/protein BSA interaction, in vitro antitumoural activity and molecular docking.
Q39871914Synthesis, modelling, and antimitotic properties of tricyclic systems characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole moiety
Q47250664Systematic exploration of multiple drug binding sites
Q35597254The Structure of an NDR/LATS Kinase-Mob Complex Reveals a Novel Kinase-Coactivator System and Substrate Docking Mechanism
Q39469128The interaction pattern between a homology model of 40S ribosomal S9 protein of Rhizoctonia solani and 1-hydroxyphenaize by docking study.
Q51552311The inverse type II β-turn on D-Trp-Phe, a pharmacophoric motif for MOR agonists.
Q80830426The studies on substrate, product and inhibitor binding to a wild-type and neuronopathic form of human acid-beta-glucosidase
Q42215981Three-Dimensional Structure of Arabidopsis thaliana Lipase Predicted by Homology Modeling Method
Q42082200Toward prediction of functional protein pockets using blind docking and pocket search algorithms
Q61812966Towards Unraveling the Histone Code by Fragment Blind Docking
Q45259690Unraveling the binding interaction and kinetics of a prospective anti-HIV drug with a model transport protein: results and challenges
Q39564721Unravelling the binding mechanism and protein stability of human serum albumin while interacting with nefopam analogues: a biophysical and insilico approach
Q46196442Using AutoDock for ligand-receptor docking
Q50133635VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition.

Search more.